End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
771,000 KRW | -0.52% | -1.15% | +1.45% |
04-25 | Samsung Bioepis Granted Approval to Market Autoimmune Treatment in Europe | MT |
04-25 | Samsung Biologics Posts Higher Q1 Profit, Sales | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+1.45% | 40.25B | |
-3.79% | 87.06B | |
-15.86% | 31.09B | |
+52.66% | 24.74B | |
-14.47% | 15.91B | |
-9.12% | 11.96B | |
-14.38% | 11.92B | |
-42.56% | 11.61B | |
+4.87% | 8.73B | |
-4.33% | 8.69B |
- Stock Market
- Equities
- A207940 Stock
- News Samsung Biologics Co.,Ltd.
- Samsung Biologics to Start Building Fifth Plant to Meet Higher Biopharmaceutical Products Demand